Faeth Therapeutics, Inc. Current Assets
Faeth Therapeutics, Inc. (FTH) had Current Assets of $188.66 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-04
- 2026-06-30: Assets, Current $188.66M.
- 2026-03-31: Assets, Current $204.23M.
- 2025-12-31: Assets, Current $21.51M.
- 2025-09-30: Assets, Current $25.79M.
| Period end | Assets, Current |
|---|---|
| 2026-06-30 | $188.66M 10-Q · filed 2026-08-04 |
| 2026-03-31 | $204.23M 10-Q · filed 2026-05-15 |
| 2025-12-31 | $21.51M 10-Q · filed 2026-08-04 |
| 2025-09-30 | $25.79M 10-Q · filed 2025-11-14 |
| 2025-06-30 | $29.57M 10-Q · filed 2025-08-05 |
| 2025-03-31 | $35.68M 10-Q · filed 2025-05-06 |
| 2024-12-31 | $41.93M 10-K · filed 2026-03-30 |
| 2024-09-30 | $48.10M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $53.94M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $60.23M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $67.25M 10-K · filed 2025-03-28 |
| 2023-09-30 | $73.84M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $81.07M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $98.61M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $108.59M 10-K · filed 2024-02-29 |
| 2022-09-30 | $118.48M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $127.49M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $138.98M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $148.54M 10-K · filed 2023-03-29 |
| 2021-09-30 | $158.16M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $165.61M 10-Q · filed 2021-08-11 |
| 2021-03-31 | $172.78M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $20.08M 10-K · filed 2022-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |